DE602005022474D1 - Beurteilung der biologischen aktivität von hgf (hepatocyte growth factor) - Google Patents

Beurteilung der biologischen aktivität von hgf (hepatocyte growth factor)

Info

Publication number
DE602005022474D1
DE602005022474D1 DE602005022474T DE602005022474T DE602005022474D1 DE 602005022474 D1 DE602005022474 D1 DE 602005022474D1 DE 602005022474 T DE602005022474 T DE 602005022474T DE 602005022474 T DE602005022474 T DE 602005022474T DE 602005022474 D1 DE602005022474 D1 DE 602005022474D1
Authority
DE
Germany
Prior art keywords
growth factor
biological activity
hepatocyte growth
hgf
assessment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
DE602005022474T
Other languages
English (en)
Inventor
Fariba Nayeri
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Peas Institut AB
Original Assignee
Peas Institut AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Peas Institut AB filed Critical Peas Institut AB
Publication of DE602005022474D1 publication Critical patent/DE602005022474D1/de
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/74—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/475—Assays involving growth factors
    • G01N2333/4753—Hepatocyte growth factor; Scatter factor; Tumor cytotoxic factor II
DE602005022474T 2004-10-20 2005-10-20 Beurteilung der biologischen aktivität von hgf (hepatocyte growth factor) Active DE602005022474D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US62061004P 2004-10-20 2004-10-20
PCT/SE2005/001583 WO2006043892A1 (en) 2004-10-20 2005-10-20 Assessment of biological activity of hepatocyte growth factor (hgf)

Publications (1)

Publication Number Publication Date
DE602005022474D1 true DE602005022474D1 (de) 2010-09-02

Family

ID=36203224

Family Applications (1)

Application Number Title Priority Date Filing Date
DE602005022474T Active DE602005022474D1 (de) 2004-10-20 2005-10-20 Beurteilung der biologischen aktivität von hgf (hepatocyte growth factor)

Country Status (6)

Country Link
US (1) US20080261233A1 (de)
EP (1) EP1810037B1 (de)
JP (1) JP2008516629A (de)
AT (1) ATE475099T1 (de)
DE (1) DE602005022474D1 (de)
WO (1) WO2006043892A1 (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE541584T1 (de) * 2005-11-16 2012-02-15 Fariba Nayeri Verfahren zur hemmung von krebsbildung und/oder metastasen bei einer person durch endogene c-met- liganden und -hemmer
US8545839B2 (en) * 2008-12-02 2013-10-01 Pierre Fabre Medicament Anti-c-Met antibody
US9157920B2 (en) 2009-06-26 2015-10-13 Peas Institut Ab Method for determining biologically active HGF
GB2519329A (en) * 2013-10-16 2015-04-22 Gm Global Tech Operations Inc Method of controlling an exhaust recirculation gas system

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2258153C (en) * 1996-07-03 2004-08-17 Genentech, Inc. Hepatocyte growth factor receptor agonists and uses thereof
US7601365B2 (en) * 2000-08-28 2009-10-13 Damavand Wound, AB Synergetic effects of HGF and antibacterial treatment
US6818907B2 (en) * 2000-10-17 2004-11-16 The President And Fellows Of Harvard College Surface plasmon enhanced illumination system
WO2004078778A2 (en) 2003-03-03 2004-09-16 Dyax Corp. PEPTIDES THAT SPECIFICALLY BIND HGF RECEPTOR (cMet) AND USES THEREOF
PL1636593T3 (pl) 2003-06-06 2009-08-31 Genentech Inc Modulowanie oddziaływania pomiędzy łańcuchem beta HGF i c-met.
JP5525162B2 (ja) 2005-12-20 2014-06-18 ボーグワーナー インコーポレーテッド ターボチャージャ付き圧縮着火エンジンシステムにおける排気ガス再循環制御方法

Also Published As

Publication number Publication date
JP2008516629A (ja) 2008-05-22
EP1810037A1 (de) 2007-07-25
EP1810037B1 (de) 2010-07-21
US20080261233A1 (en) 2008-10-23
WO2006043892A1 (en) 2006-04-27
ATE475099T1 (de) 2010-08-15

Similar Documents

Publication Publication Date Title
BRPI0507680A (pt) partìculas de fosfato de cálcio terapêuticas e métodos de fabricação e uso das mesmas
NO20070951L (no) Inhibitorer av angiopoientinlignende-4-protein, kombinasjoner og deres anvendelse.
ATE286118T1 (de) Anwendungen für humane nicht autologe, mesenchymale stammzellen
IL190991A (en) Causes of cardiac infarction and delay of left ventricular remodeling after cardiac infarction containing antibody that identifies IL-6 receptor as active substance
BRPI0519430A2 (pt) hormânio do crescimento humano modificado
TW200505478A (en) Immunoglobulin formulation and method of preparation thereof
NO20070293L (no) Aryl-substituerte piperazinderivater
DE602006017071D1 (de) Zusammensetzungen und verfahren zur behandlung von herzkrankheiten
DE60121027D1 (de) Lösung zur evaluierung und konservierung
DE602005026105D1 (de) Verwendung von agonisten und antagonisten von interleukin-33 (il-33)
BRPI0507812A (pt) sistema de microativação, método para a microativação das células epidérmicas, kit, método para montar o dispositivo de microativação e método para a microativação da pele
SG196821A1 (en) New stable formulations of recombinant human albumin-human granulocyte colony stimulating factor fusion protein
TW200616632A (en) Compounds modulating c-kit activity and uses therefor
NO20070950L (no) Preparater og fremgangsmater for anvendelse av angiopoietinlignende-4-protein.
ATE531383T1 (de) Therapeutische verwendung eines wachstumsfaktors, metrnl
WO2007143098A8 (en) Hepatocyte growth factor (hgf) binding proteins
BRPI0406605B8 (pt) conjugado de proteína, método para a preparação do mesmo e composição farmacêutica para intensificar a duração e estabilidade in vivo de um polipeptídeo fisiologicamente ativo
WO2007143090A3 (en) Hepatocyte growth factor (hgf) binding proteins
ATE538136T1 (de) Antikörper gegen connective tissue growth factor
DK1709161T3 (da) Humane terapeutiske celler, som udskiller nervevækstfaktor
WO2007011606A3 (en) USE OF HMGBl ANTAGONISTS FOR THE TREATMENT OF INFLAMMATORY SKIN CONDITIONS
DE602005010246D1 (de) Oligopeptide zur verringerung erhöhter blutharnstoffkonzentration
CY1118073T1 (el) Συνθεσεις και μεθοδοι για την αυξηση της δρασης της τελομερασης
ATE527378T1 (de) Antisense-modulation von p38-mitogen-aktivierter proteinkinase-expression
ATE512146T1 (de) Phenylharnstoffderivate als hemmstoffe von tyrosinkinasen zur behandlung von tumorerkrankungen